GlassScriptPhysician profile
Darshan Shah
NPI 1710347588
$13,293.21
in general payments reported to CMS, 2019-2025
14 companies · $3,265 in 2025
The $3,265 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,012 · 2020: $1,577 · 2021: $2,785 · 2022: $2,648 · 2023: $217 · 2024: $790 · 2025: $3,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,270 · Food and Beverage: $2,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,270.21 |
| Food and Beverage | $2,001.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $4,138.26 | 2021-2024 | |
| Medinc of Texas | $4,093.66 | 2019-2021 | |
| Stryker Corporation | $2,045.81 | 2019-2025 | Mako, T2 Alpha, Salvation |
| Smith+Nephew, INC. | $1,119.39 | 2025 | Journey II, Real Intelligence, Legion |
| Zimmer Biomet Holdings, INC. | $560.00 | 2025 | Persona |
| Medical Device Business Services, INC. | $350.33 | 2025 | Velys |
| Depuy Synthes Sales INC. | $250.47 | 2025 | |
| Skeletal Dynamics INC | $193.32 | 2021 | |
| Orthalign INC | $190.41 | 2019-2023 | Orthalign Plus |
| Aesculap Implant Systems, LLC | $116.82 | 2020 | |
| Medacta USA, INC. | $88.35 | 2023 | Amistem |
| Pacira Pharmaceuticals Incorporated | $82.03 | 2019 | |
| Novus Surgical Consultants | $49.94 | 2025 | |
| Music City Medical Technologies, LLC | $14.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.